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People and dogs with 
cancer may benefit  
from similar therapies
Canine
CONNECTION
151352_OBC_OFC_CS6.indd  3 4/15/15  10:11 PM
Published by Washington University School of Medicine, 
Office of Medical Public Affairs, Campus Box 8508,  
4444 Forest Park Ave., St.  Louis, MO 63108  © 2015
PHONE (314 ) 286-0100    EMAIL mpa@wustl.edu 
MANAGING EDITOR  DEB PARKER     
ASSISTANT EDITOR, DESIGNER  ERIC YOUNG
EXECUTIVE EDITOR  DONNA HEROUX     
PHOTOGRAPHER  ROBERT BOSTON     
CIRCULATION  KATHI LAW
WEB PRODUCTION  SAM HERMES AND  
THE MAGAZINE STAFF 
facebook.com/WUSTLmedicine.health   
@WUSTLmed
Outlook Spring 2015
outlook.wustl.edu   
Perfectly matched
Justin Krogue brought along his son,  
1-year-old Miles (dressed in baby-sized 
scrubs), and wife, Marissa, to Match Day 
festivities March 20 in the Eric P. Newman 
Education Center. The envelope contained 
big news: The family will relocate to the 
University of California, San Francisco, where 
Justin will train in orthopedic surgery. To 
learn the fate of more than 120 transitioning 
School of Medicine students, see page 24.
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 2  Chikungunya 
   reaches the U.S.
COVER  Researchers at the School of 
Medicine and the Auburn University College of 
Veterinary Medicine in Alabama are working 
together to develop cancer therapies for 
people and their animal companions. The 
researchers have collaborated for 20 years in 
an effort to make viral-based cancer 
treatments a reality for both dogs and people. 
To learn more about this human-animal 
connection, see page 12.   
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very mosquito season brings with 
it the fear that these annoying 
insects could arrive carrying a 
dangerous disease. One such infection has 
recently been detected in the U.S.
Known as Chikungunya, an African word 
for “that which bends up,” this mosquito-
borne virus causes arthritis-like symptoms. 
The virus is mainly spread by the tropical 
Aedes aegypti mosquito and first was identi-
fied 60 years ago in eastern Africa. Since 
then, it has spread across the world.
In 2014, more than 2,000 people in the 
U.S. developed the infection after traveling 
abroad, mostly to the Caribbean. That same 
year, 11 cases of Chikungunya infection 
were reported among people living in 
Florida who had not traveled outside the 
U.S., suggesting that mosquitoes in that 
state were spreading the virus.
In most patients, the infection causes a 
fever, rash and severe joint pain. The fever 
and rash typically subside in seven to 10 days, 
but symptoms of arthritis may persist in up to 
60 percent of patients for a year or longer. 
Researchers at Washington University 
School of Medicine have found that blood 
tests of patients carrying the Chikungunya 
virus and those with rheumatoid arthritis can 
produce similar results. This may lead to the 
misdiagnosis of some patients with the virus.
The findings underscore the need for 
doctors to obtain detailed travel and medical 
histories from patients being evaluated for 
rheumatoid arthritis. Such details could help 
distinguish between the two conditions.
The global spread of the Chikungunya 
virus suggests that the disease is likely to 
provide a diagnostic challenge in the years 
ahead. Physicians treat rheumatoid arthritis 
with drugs that suppress the immune sys-
tem, but it’s not yet known whether that 
approach will help or harm patients with 
Chikungunya virus.
“We’re anticipating that Chikungunya 
virus will spread broadly in the U.S., so it’s 
important to develop better tools for diag-
nosis, prevention and treatment,” said 
Deborah J. Lenschow, MD, PhD, a rheumatol-
ogist involved in the research. Researchers 
here have established an online 
Chikungunya registry. 
Arthritis-like virus makes its way to U.S. via a tropical mosquito
Airborne invasion
E
Spring 2015
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Online registry for 
Chikungunya cases
chikv.dom.wust l.edu
Global incidence of  
Chikungunya as of  
Spring 2015
This unwelcome  
visitor, the Aedes  
aegypti mosquito,  
comes bearing 
Chikungunya.
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Larry J. Shapiro, MD, has announced he will step down as 
executive vice chancellor for medical aairs and dean of the 
School of Medicine.
Shapiro, who has led the school for nearly 12 years, will 
continue at the helm until a national search is conducted and 
his replacement found.
Chancellor Mark S. Wrighton is chairing the search 
committee, which includes the provost, university trustees, 
School of Medicine department heads and others.
Wrighton, referring to Shapiro as “St. Louis’ physician-in-
chief” and a leader devoted to the university and medical school, 
said it is impossible to recount all of Shapiro’s achievements.
“Larry has done a terric job in every respect: e school 
has never been stronger, and he has done fabulously well 
in recruiting outstanding department heads and faculty; 
recruiting the most outstanding medical students; and build-
ing an outstanding and large clinical program, including 
development of the Alvin J. Siteman Cancer Center.
“He was instrumental in launch-
ing the Institute for Public Health 
and supporting its development,  
and he played a lead role in enhanc-
ing the school’s educational mission 
and in strengthening the quality  
and impact of research.”
Shapiro said his leadership role  
at the university “has been the 
utmost privilege of my professional 
career and has provided me with 
challenges, great satisfaction and much happiness.”
A pediatric geneticist by training, Shapiro is a 
Washington University legacy. He rst arrived in St. Louis 
50 years ago as an undergraduate student in Arts & Sciences. 
He then pursued his medical degree at the School of 
Medicine and completed his residency at St. Louis Children’s 
Hospital in 1973.
Aerward, he embarked on a medical career at the 
National Institutes of Health (NIH) and then at the 
University of California, Los Angeles, and the University  
of California, San Francisco. He returned to St. Louis in 
2003 as a renowned genetics researcher, administrator and 
pediatrician. at year, he took on the roles of executive  
vice chancellor for medical aairs, dean of the School  
of Medicine and the Spencer T. and Ann W. Olin 
Distinguished Professor.
He is also president of Washington University Medical 
Center, which includes the School of Medicine, Barnes-Jewish 
Hospital and St. Louis Children’s Hospital. 
Study may aid stroke recovery
Stroke can lead to a wide range of problems such as depres-
sion and diculty moving, speaking and paying attention. 
Scientists have thought these issues were caused by damage 
to the brain’s “computer processors” — cells in the brain’s 
outer layer that do much of the work involved in higher 
brain functions.
But a new study by School of Medicine 
researchers has found compelling evidence 
that stroke damage to “cables” buried inside 
the brain plays an important role in these 
impairments. e cables connect cells on  
the brain’s surface to each other, to other 
cells deep in the brain and to cells in the  
spinal cord that link the brain to the rest  
of the body.
“is study provides a new framework to 
think about the damage caused by stroke,” 
said senior author Maurizio Corbetta, MD, the Norman J. 
Stupp Professor of Neurology. “A more complete and accu-
rate description of the most common anatomical damage 
and decits aer a stroke will help us understand how the 
brain can adapt to recover lost functions and potentially  
lead to new rehabilitation strategies.”
To get a better sense of how stroke damages the brain, 
Corbetta and his colleagues initiated a study of 132 patients 
who had just suered rst-time strokes. e results appeared 
online March 4 in Neuron. 
Shapiro’s legacy
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Maurizio Corbetta, MD
Larry J. Shapiro, MD
Sparking interest  The Office of Diversity Programs 
annually selects 50 students from St. Louis City and County high 
schools to participate in a four-week human anatomy and physiology 
course taught by Will Ross, MD, MPH, associate dean for diversity, 
along with medical students. At the program’s end, the high school 
students present on a medical topic that they have researched using 
the Internet and library resources, with the assistance of the Bernard 
Becker Medical Library staff.  The program seeks to improve diversity 
in the future medical and scientific workforce.
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Antibiotic resistance is poised to spread globally among  
bacteria implicated in respiratory and urinary infections  
in hospital settings, according to new research.
Two genes that confer resistance 
against a particularly strong class of 
antibiotics can be shared among a  
family of bacteria responsible for a  
signicant portion of hospital- 
associated infections, the study shows.
Drug-resistant germs recently 
infected several patients at two Los 
Angeles hospitals. e infections have 
been linked to medical scopes possibly 
contaminated with bacteria resistant  
to carbapenems, potent antibiotics for use only in gravely  
ill patients or those infected by resistant bacteria.
“Carbapenems are one of our last resorts for treating 
bacterial infections, what we use when nothing else works,” 
said senior author Gautam Dantas, PhD, associate professor 
of pathology and immunology. “Given what we know now, 
I don’t think it’s overstating the case to say that for certain 
types of infections, we may be looking at the start of the 
post-antibiotic era, a time when most of the antibiotics we 
rely on to treat bacterial infections are no longer eective.”
Dantas and others recommend limiting the usage of  
carbapenems to cases in which no other treatments can help. 
e study, conducted by researchers at Washington 
University, Barnes-Jewish Hospital and the National 
University of Sciences and Technology in Pakistan, is  
available online in Emerging Infectious Diseases.
Start of ‘post-antibiotic’ era?
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Two named AAAS fellows School of Medicine 
faculty members Mary C. Dinauer, MD, PhD, and David M. Holtzman, 
MD, have been named fellows of the American Association for the 
Advancement of Science. Dinauer is the Fred M. Saigh Distinguished 
Chair in Pediatric Research at St. Louis Children’s Hospital and pro-
fessor of pediatrics and of pathology and immunology. Holtzman 
is the Andrew B. and Gretchen P. Jones Professor and head of the 
Department of Neurology.
School of Medicine researchers have developed a noninvasive 
method to screen for kidney cancer that involves measur-
ing the presence of proteins in the urine. e ndings are 
reported March 19 in the journal JAMA Oncology.
e researchers found that the protein biomarkers were  
more than 95 percent accurate in identifying early-stage  
kidney cancers. In addition, there were no false positives 
caused by non-cancerous kidney disease.
“ese biomarkers are very sensitive and specic to kid-
ney cancer,” said senior author Evan D. Kharasch, MD, PhD.
Like most cancers, kidney tumors are easier to treat when 
diagnosed early. But symptoms of the disease, such as blood 
in the urine and abdominal pain, oen don’t develop until 
later, making early diagnosis dicult.
“e most common way that we nd kidney cancer is as 
an incidental, fortuitous nding when someone has a CT 
or MRI scan,” said Kharasch, the Russell D. and Mary B. 
Shelden Professor of Anesthesiology. “It’s not aordable to 
use such scans as a screening method, so our goal has been 
to develop a urine test to identify kidney cancer early.”
With researchers from the Alvin J. Siteman Cancer 
Center, the Mallinckrodt 
Institute of Radiology 
and the Division of 
Urologic Surgery, 
Kharasch and principal 
investigator Jeremiah J. 
Morrissey, PhD, professor 
of anesthesiology, ana-
lyzed urine samples from 
720 patients at Barnes-
Jewish Hospital who were 
about to undergo abdom-
inal CT scans for reasons 
unrelated to suspicion of 
kidney cancer. 
Results of the scans let the investigators determine 
whether patients might have kidney cancer. As a comparison, 
they also analyzed samples from 80 healthy people and 19 
patients previously diagnosed with kidney cancer.
e researchers measured levels of two proteins in the urine 
— aquaporin-1 (AQP1) and perlipin-2 (PLIN2). None of the 
healthy people had elevated levels of either protein, but patients 
with kidney cancer had elevated levels of both proteins.
About 15 percent of kidney masses found by CT scans 
are not malignant. e only way to know denitively is to 
operate. Kharasch and Morrissey are using the ndings to 
develop an easy-to-use, more widely available screening test. 
Earlier diagnosis
Currently, surgery is the only  
way to diagnose kidney cancer.
Kidney cancer detected with urine test
‘Superbugs’ pose a threat
CENTERS FOR
DISEASE CONTROL
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t’s a firmly established fact straight from 
Biology 101: Traits such as eye color and 
height are passed from one generation 
to the next through the parents’ DNA. 
But now, a new study in mice by School 
of Medicine researchers has shown that the 
DNA of bacteria in the body can pass a trait to 
offspring in a way similar to the parents’ own 
DNA. According to the authors, the discovery 
means scientists need to consider a significant 
new factor – the DNA of microbes passed from 
mother to child – in their efforts to understand 
how genes influence illness and health. The 
study appeared online Feb. 16 in Nature.
“We have kept bacteria on one side of 
a line separating the factors that shape our 
development — the environmental side of 
that line, not the genetic side,” said co-senior 
author Herbert W. Virgin IV, MD, PhD.
 “But our results show bacteria stepping 
over the line. This suggests we may need to 
substantially expand our thinking about their 
contributions, and perhaps the contributions 
of other microorganisms, to genetics and 
heredity.”
Bacterial DNA also shapes inheritance
I
G E N E T I C S
Bacteria are known for their roles in  
harmful infections. But scientists have real-
ized that such bacteria are only a tiny fraction 
of the bacterial communities that live in and 
on our bodies. Most bacteria are commensal, 
which means they do not cause harm and 
often confer benefits.
Commensal bacteria influence traits 
such as weight and behavior. But until now, 
researchers thought the bacteria that exerted 
these effects were acquired during a person’s 
life. The study is the first to show that bacte-
rial DNA can pass from parent to offspring in 
a manner that affects specific traits such as 
immunity and inflammation. 
The researchers linked commensal bacteria 
in mice to gut injury susceptibility. Mice with 
certain inherited bacteria are susceptible to 
the injury, which is caused by exposure to a 
chemical. Female mice pass the bacteria to 
their offspring, making them vulnerable to  
the injury. Others carrying different bacteria 
are less susceptible. 
In the short term, the findings may help 
scientists eliminate a significant “bug” in stud-
ies of genetically engineered mice. In several 
fields of research, scientists have been con-
fronted intermittently with the sudden, unex-
plained appearance of new or altered traits in 
mice. The traits often spread from one mouse 
habitat to the next, suggesting a spreading 
microbial infection is responsible. But the 
traits also consistently pass from mother to 
offspring, suggesting a genetic cause. 
In the long term, Virgin expects the 
expanded model of heredity to produce 
a more complicated but also much more 
insightful picture of how human, bacterial  
and viral genes influence human health.
Specialty center 
will focus on kids
The St. Louis Children’s Specialty Care Center, sched-
uled to open in June 2015, is a new outpatient facility 
focused exclusively on pediatric patients. Washington 
University Physicians and St. Louis Children’s Hospital 
pediatric nurses and staff will provide a wide range of 
services at the facility, located in west St. Louis County 
at Highway 40/I-64 and Mason Road.
The center is being designed as an uplifting 
and creative environment that reduces stress, 
promotes healing and provides a superior patient 
experience. The facility also offers three operating 
rooms and a variety of imaging, lab and therapy 
services. Space is available for classes on CPR, 
babysitting and staying home alone, among  
other topics. 
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A Washington University drug discovery program has 
received three grants totaling more than $5 million from the 
National Institutes of Health (NIH) to develop new thera-
peutics for respiratory diseases. e target illnesses range 
from the common cold to life-threatening lung disease. 
e projects include designing next-generation drugs 
to open the airway passages by controlling mucus produc-
tion, as well as new agents to ght o respiratory infections 
by boosting the immune system. e program, based in 
the Division of Pulmonary and Critical Care Medicine in 
the Department of Medicine, is led by pulmonologist and 
principal investigator Michael J. Holtzman, MD, the Selma 
and Herman Seldin 
Professor of Medicine. 
“Chronic respiratory 
disease is the third-
leading cause of death 
in the U.S. and the h 
worldwide, and these 
deaths are linked most 
strongly to overproduc-
tion of inammatory 
mucus that blocks the 
airways,” he said. “e 
pathway to mucus pro-
duction is invariably 
activated in respiratory 
viral infections, and 
the same process drives exac-
erbations and progression of 
chronic respiratory diseases 
like asthma and COPD, yet 
there are no drugs that eectively control this pathway.”
e largest award, totaling just over $3 million,  
will support a project focused on optimizing a chemical  
compound Holtzman’s group developed to block a key 
checkpoint in the mucus pathway. 
Two other awards totaling $2.5 million will address the 
need to control viruses that drive acute and chronic respira-
tory disease. ese awards are designed to develop the next 
generation of antiviral drugs. ere is a crucial need for 
drugs that battle common viruses that cause respiratory  
illness. To address this issue, Holtzman’s group came up 
with a strategy to improve the body’s interferon signaling 
pathway, the main means for antiviral defense. 
e Drug Discovery Program, in its fourth year  
of operation, is envisioned as a model for academic  
development of new therapeutics.
Respiratory gamut
Targetings colds, COPD and more
 The research holds  
promise for developing  
a range of therapies.
Look for
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In the spotlight Recipients of the 2014 2nd Century 
Awards: (from left) Scott J. Hultgren, PhD, Carol B. Loeb and  
F. Sessions Cole, MD. The 2nd Century Awards recognize those whose 
long-term commitment and participation have helped the School 
of Medicine enter its second century with strength and confidence. 
Hultgren was honored for research focused on microbial-host 
interactions and his work on how infectious diseases are diagnosed, 
treated and prevented. Loeb was honored for personal and profes-
sional dedication to the advancement of education. Cole was  
honored for achievements in improving outcomes for newborns. 
New research indicates that hormonal intrauterine devices 
(IUDs) and contraceptive implants remain highly eective 
one year beyond their approved duration of use, according  
to a School of Medicine study. e preliminary ndings  
are reported in Obstetrics & Gynecology.
Researchers are evaluating whether 
such long-acting forms of birth control 
are eective for up to three years past the 
length of use approved by the Food and 
Drug Administration (FDA). Contraceptive 
implants — matchstick-sized rods inserted 
into the arm — are approved for three 
years, and hormonal IUDs are approved 
for ve years. Extended use of these devices 
reduces cost to individuals and insurers, 
said rst author Colleen McNicholas, DO, 
assistant professor of obstetrics and gynecology.
ese long-acting contraceptive methods are garnering 
renewed attention in the U.S. because of their superior  
eectiveness over other forms of birth control. e study 
aims to enroll a total of 800 women. 
“In the long term, this work has the potential to  
change how we provide contraceptive methods around the  
world and can enable women to control their reproductive  
health and family size,” said senior author Jerey Peipert, 
MD, PhD, the Robert J. Terry Professor of Obstetrics  
and Gynecology. 
Evaluating long-acting birth control
Demonstrating a hormonal 
intrauterine device (IUD) 
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Clinical studies begin on a tiny technology 
that could pinpoint arterial disease risks
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In patients with atherosclerosis, plaque accu-
mulates on the inner walls of arteries, which 
deliver blood to the body. In many cases, the accu-
mulated plaque causes no symptoms and remains 
undiagnosed by physicians. Plaque accumulation 
eventually can narrow an artery enough to cause 
chest pain or mild symptoms. But, for some, this 
plaque suddenly can rupture without warning, 
create blockages and cause a heart attack or stroke.
“Plaque is a complex structure, made up of cho-
lesterol, calcied deposits and other substances, 
all of which can cause plaque instability,” said 
Woodard, also director of the Center for Clinical 
Imaging Research (CCIR) at the Mallinckrodt 
Institute of Radiology at Washington University. 
“is imaging agent targets a specic receptor 
that is present in more vulnerable complex plaque, 
thereby identifying which plaques might rupture 
in the patient, leading to stroke or heart attack.”
Past research shows most patients with plaque 
narrowing a carotid artery will not go on to have 
a stroke.
Distinguishing high-risk patients
“With current technology, such as ultrasound,  
we can’t tell whether the plaque is vulnerable  
or stable,” she said. “So we can’t distinguish  
the high-risk patients who need surgery from  
low-risk patients who can be treated with  
medication alone.
“We designed this nanoparticle agent to 
develop a test that can detect these vulnerable 
plaques and identify those patients at highest  
risk of stroke and in need of surgery to remove  
the plaque.”
Gregorio A. Sicard, MD, vascular surgeon and 
professor of surgery and of radiology, said special-
ists who treat carotid artery disease have been 
seeking a diagnostic test that could identify extra-
cranial carotid artery disease, which is more prone 
to embolize, rupture or occlude the carotid artery. 
ese types of vulnerable plaques are more likely 
to cause an embolic cerebral vascular event with 
devastating eects. In many cases, these patients 
are asymptomatic.
 “is exciting work by Dr. Woodard and  
collaborators may provide a screening imaging 
study that will identify, in asymptomatic patients, 
those that have a vulnerable plaque and are there-
fore more likely to have a cerebral vascular event,” 
Sicard said. “is cutting-edge diagnostic study 
hopefully will revolutionize the management of 
patients with asymptomatic carotid plaque and 
plaque in other arterial beds.”
A new nanoparticle-based imaging agent 
may help identify patients at high risk of stroke by 
revealing dangerous plaque in arteries. The Food and 
Drug Administration (FDA) has approved the agent 
for investigational use in people. The technology was 
jointly developed at Washington University School 
of Medicine and the University of California, Santa 
Barbara, in collaboration with Texas A&M University. 
“This is the first receptor-targeted nanoparticle 
agent for cardiovascular imaging approved for inves-
tigational use in humans,” said principal investigator 
Pamela K. Woodard, MD, professor of radiology and of 
biomedical engineering. “Starting with bench research, 
then developing and testing the agent and taking 
it through the FDA process into human patients has 
involved an extensive team of basic scientists, clinical 
researchers and clinicians.”
Pamela K. Woodard, MD
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How it works
e nanoparticle is unique in how it is targeted, 
according to Yongjian Liu, PhD, assistant profes-
sor of radiology and co-investigator on the project. 
Previous research demonstrated that a receptor 
called NPR-C is present on the surface of cells  
that line blood vessels and is increased in plaque 
associated with atherosclerosis. So the investiga-
tors added a small peptide to the nanoparticle.  
at peptide seeks out and binds to NPR-C,  
specically targeting the particle to potentially 
dangerous plaque.
e nanoparticle also carries copper atoms, 
making it visible with a standard positron emis-
sion tomography (PET) scanner. Similarly, small 
amounts of copper-64 are used in PET scans for 
cancer detection and therapy and neurologic 
imaging. Once injected, this nanoparticle agent 
can illuminate potentially vulnerable plaque in  
the body’s arteries. 
e carrier nanoparticle was craed in the  
lab of Craig J. Hawker, PhD, professor and  
director of the California Nanosystems Institute  
at the University of California, Santa Barbara.  
“We couldn’t carry out the research without his 
contributions,” Woodard said.   
Following successful tests in animal models, 
researchers recently began testing the safety of  
the nanoparticle in healthy individuals. Next,  
they will focus on patients with atherosclerosis 
who already are scheduled to undergo surgery  
to remove plaque from their carotid arteries.
Testing of these patients will begin in a novel 
PET-MR system housed in the CCIR, so that the 
researchers can look at plaque anatomy on MRI 
and PET signals from the new agent concurrently.
“We’ll be able to see whether the areas that 
light up in the image because of our nanoparticles 
are the same areas that contain vulnerable plaque, 
as assessed from the surgeries,” Woodard said. 
Once the investigators demonstrate success 
imaging the carotid arteries, they will evaluate the 
nanoparticle agent in other vessels such as the cor-
onary arteries, which represent a greater challenge 
because of their smaller size and complex motion.
“Given the clinical success of this agent, 
with the assistance of the Oce of Technology 
Management, we have begun seeking to advance 
this imaging agent into a commercial product,” 
Woodard said.  
“We have been able to develop this highly 
receptor-specic imaging technology because of 
the generous support from the National Heart, 
Lung and Blood Institute, our diverse and dedi-
cated team of investigators and our extensive 
facilities at Washington University,” she added. 
ARTERIAL PLAQUE
RECEPTORS
BLOODSTREAM
PEPTIDES
Miniaturized medicine
The nanoparticle-based imaging agent carries custom  
peptide molecules that bind to the receptors of unstable 
plaques. First, the peptides are attached to nanoparticle 
“combs,” left, which morph into star-like shapes when wetted. 
Injected into the bloodstream, legions of these stars descend 
on dangerous plaques, shining brightly on radiologic images. 
The Center for Clinical 
Imaging Research provides 
advanced imaging resources 
and support for clinical 
investigators.
LEARN MORE  
ccir.wustl.edu
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Today, as a result of newborn hearing screenings, advanced technologies and early intervention programs, more and more children with hearing loss 
are being mainstreamed into classrooms alongside hearing 
peers. With individualized support and assistive devices, such 
as cochlear implants, these children thrive academically. But, 
though they may excel in speech and listening, oen, they  
feel socially isolated.  n  Alumna Melanie Patico is working 
to help them combat these feelings, providing a point of 
connection for kids and teens with hearing loss around the 
world. Last year, she launched Hearing Our Way, the only 
such magazine for children and teens. e goal: Bring hearing-
impaired young people together through shared experiences.
Celebrating differences
Kids with hearing loss must 
overcome obstacles beyond the 
usual struggles growing up. 
One impassioned alumna 
is providing an uplifting 
resource worldwide. 
Alumna Melanie Paticoff,
MSDE ’13, with her mentor
Heather Hayes, PhD, director
of deaf education studies in
the Program in Audiology and
Communication Sciences.
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Closing a gap
Growing up in Long Island, New York, Patico 
was inspired by her cousin Julie, now 19. As 
Patico explains, Julie listens to her iPod, attends 
concerts and is a member of a dance team. She 
also is profoundly deaf. Bilateral cochlear implants 
give her complete access to sound. 
“ere are 3 million other kids in the U.S.  
just like Julie and millions more around the 
world,” Patico said. “ey attend school with 
their friends, join clubs and play sports, but  
they are usually the only ones with hearing  
loss in their entire school district.” 
Oen, these children haven’t spent any  
time in schools for the deaf and have had little 
exposure to other kids with hearing loss. 
While pursuing degrees in deaf education, 
Patico witnessed a gap in social and emotional 
support for children with hearing loss. She 
noticed, for example, that children’s literature 
rarely depicts characters with hearing loss. is 
inspired her to write and self-publish two award-
winning children’s books featuring Sophie, a 
ctional dog with a cochlear implant — “Sophie’s 
Tales: Learning to Listen” (2010) and “Sophie’s 
Tales: Overcoming Obstacles” (2012). 
In 2011, Patico earned a bachelor’s degree in 
deaf education from Fontbonne University and, in 
2013, a master’s degree from Washington University’s 
Program in Audiology and Communication 
Sciences (PACS), where she received the Max A. 
Goldstein Award for outstanding academic 
achievement and professional promise. 
“Melanie was a special student from the very 
beginning,” said Patico’s mentor Heather Hayes, 
PhD, director of deaf education studies. 
“Her drive to help children who are deaf and 
who learn to listen and talk was unparalleled.  
It was my distinct pleasure to be one of her  
mentors, and I take great pride in it still.” 
Reaching out
Aer graduating in May 2013, Patico began 
developing the magazine that summer. e  
rst issue arrived in homes a year later, and a  
successful crowdfunding campaign followed.
e quarterly magazine, which includes  
inspirational stories, language tips and tricks,  
self-advocacy skills and interviews with teens  
who have faced similar obstacles, is oered free. 
“e magazine teaches kids and teens to  
celebrate their dierences and provides vital  
social and emotional support to young people  
during their formative years,” Patico said.
 Filled with positivity and pop culture refer-
ences, a recent issue contained song lyrics from 
the Jonas Brothers and advice on hairstyles that 
work well with cochlear implants. 
Five thousand subscribers signed up in the  
rst two months — with readers across the U.S. 
and as far away as Australia and Italy. Now,  
there are 10,000 subscribers.
“Melanie is reaching out to children across the 
country (and the world) with her publication,” 
Hayes said. “Most importantly, she’s also reaching 
families, audiologists and physicians who might 
not even realize how valuable a magazine like  
this can be to young children and adolescents.  
Just simply seeing images of children with devices 
like hearing aids and cochlear implants in a fun 
publication can mean the world to a child.  
Celebrating differences
Reinforcing positive  
experiences for hearing-
impaired children 
LEARN MORE  
HearingOurWay.com
“Deafness is a low-incidence disability  
and, thus, many children and parents struggle  
to nd common experiences with others.
“Additionally, Mel is bringing awareness to  
others about how children who are deaf can  
learn to listen and talk. is is invaluable.”
e partnership between the magazine and 
the medical school is still strong nearly two years 
post-graduation. PACS is a magazine sponsor, and 
every issue spotlights a current deaf education or 
audiology student at the medical school. A recent 
issue featuring a graduate student with hearing 
loss helped further illustrate that those with  
hearing impairment can go on to become  
audiologists, teachers or leaders in other elds.
Patico resides in St. Louis as editor-in-chief  
of Hearing Our Way and chief executive ocer  
of Sophie’s Tales LLC. 
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Sophie, a spunky 
Maltipoo that proudly 
wears a purple 
cochlear implant, is 
based on Paticoff’s 
real-life pet, a 
certified therapy dog.  
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Shared
H U M A N S  A N D  D O G S  have lived alongside one 
another for millennia. Dogs have provided protection and 
companionship, labor and love. ey have worked our farms, 
hunted our food, guarded our livestock, played with our kids  
and evolved with us. It’s a unique relationship, unrivaled by  
any other set of species. And while we may recognize many of 
the mutually benecial aspects of this bond, a new paradigm is 
emerging between man and his best friend: shared medicine.
It’s no secret that animals and people share many of the 
same diseases. Testing possible treatments for people on animals, 
especially laboratory mice, is a mainstay of medical 
research and the origin of most modern therapies.  
But physicians are realizing how much stands to 
be learned by collaborating with veterinarians and 
designing clinical trials for animals — to treat their 
naturally occurring diseases — just as we do in people. 
e lesson has been embraced by Washington University’s 
David T. Curiel, MD, PhD, a professor of radiation oncology and 
of cancer biology. Much of Curiel’s research focuses on the use 
of engineered viruses to treat disease, especially cancer. He and 
veterinarians at Auburn University in Alabama are cultivating 
partnerships they hope will speed the development  
of cancer therapies for people and their animal companions. 
“People love their pets and want to treat them when they  
get cancer,” Curiel said. “And dogs get cancers that  
are very similar to human cancers.” 
Canine companions share  
our lives. They even get similar 
cancers. These connections 
suggest a new frontier of 
mutually beneficial therapies.
medicine
An experimental cancer therapy
may have benefited greyhound
Pretty, right, who lived more than
twice as long as the average for her
condition. Nancy Hunter learned of
the program through a web search.
B Y  J U L I A 
E V A N G E L O U  
S T R A I T
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At rst, Dawn Oravetz thought her rescue grey-
hound Gary had simply tripped and bruised his 
right rear leg. Or, at age 10, perhaps some arthritis 
was developing in his joints, especially since Gary 
had spent his early life sprinting around racetracks 
at 40 miles per hour. Oravetz hoped it was just a 
bruise, but she had good reason to worry. 
Greyhounds, especially those bred for racing, 
and other large-breed dogs are at above average 
risk of developing a type of bone cancer 
called osteosarcoma. Osteosarcoma is 
also one of the more common cancers 
of human adolescence, emerging 
with teenage growth spurts. In 
dogs, the tumor tends to be partic-
ularly aggressive. Standard treat-
ment is amputation of the aected 
leg followed by several rounds of 
chemotherapy. e tumor oen 
spreads to the lungs. Even with 
aggressive treatment, prognosis is 
poor. Greyhounds survive an average  
of only nine months aer diagnosis. 
Oravetz and her husband, Bill, understood 
this better than most, already having lost two 
adopted greyhounds to the disease. 
rough contacts in a local greyhound rescue 
organization, Oravetz learned of a clinical trial  
at Auburn’s College of Veterinary Medicine,  
about a four-hour drive from their home in 
Navarre, Florida. 
“We learned from past experience that you 
don’t put it o,” Dawn Oravetz said. “We found 
out about Gary’s tumor on a Saturday. And by 
ursday, we were at Auburn.”
e director of Auburn’s cancer research  
initiative, Bruce F. Smith, VMD, PhD, has been 
collaborating with Curiel for more than 20 years, 
in an eort to make virus-based cancer treatments 
a reality for both dogs and people. 
A major barrier to research and development 
of viral cancer treatments is that they cannot be 
tested in traditional mouse models. 
“Human adenoviruses don’t replicate in mice,” 
Curiel said. “But we thought, what if we take a 
virus that normally infects dogs and use it to 
treat dog tumors? Now you have a virus that can 
replicate in the tumor. e animals have working 
immune systems and are genetically diverse.  
In theory, this fully mimics what we want to  
do in humans. It’s a more stringent test of the  
system. And you may end up with a new therapy 
for dogs in the process.”
Curiel and Smith emphasize that Gary and 
dogs like him are not experimental animals. As  
in people, their cancers develop spontaneously, 
probably due to some interaction between genes 
and environment. ey don’t live in controlled 
laboratory settings with identical diets. ese  
dogs live at home with their families. And perhaps 
most importantly for this particular kind of trial, 
they have intact immune systems, unlike mice so 
commonly used in cancer research. In short, if a 
clinical trial of an investigational therapy works  
in dogs living in the real world, it may be more 
likely to work in the people who live with them. 
It started with a limp. 
Building 
viral-based 
therapiesBruce F. Smith, VMD, PhD,  
of Auburn University College 
of Veterinary Medicine, 
collaborates with researchers 
at Washington University 
School of Medicine in 
pursuit of virus-based cancer 
treatments that could benefit 
dogs as well as humans.
Greyhound Gary’s  
dedicated owners 
quickly responded 
to the signs that he 
could have cancer.
AU
BU
RN
 U
NI
VE
RS
IT
Y 
PH
OT
OG
RA
PH
IC
 S
ER
VI
CE
S
151352_12-17_Dogz_CS6.indd   14 4/15/15   7:02 PM
outlook.wustl.edu Outlook  15
Building 
viral-based 
therapies
1
3 4
2
Making custom cancer-destroying viruses requires meticulous teamwork. 
In the Curiel lab, that collaboration is fostered by two husband-and-wife 
partnerships: Igor Dmitriev (1) and Elena Kashentseva (3), and Sergey 
Kaliberov (2) and Lyudmila Kaliberova (4), all Russian émigrés who 
brought their scientific skills to Washington University School of Medicine.
The process begins with a procedure  
that reprograms viral DNA so it can  
target cancer cells.
A whirl in the centrifuge separates the virus 
from the packaging cells. Testing reveals bands 
of pure virus (see arrows at edge of this page).
Specialized packaging cells house the virus, 
supply necessary cellular functions and allow  
the virus to grow and multiply.
Finally, the scientists verify that the new  
batch of virus will spare healthy cells and  
kill tumor cells when used in clinical trials.
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As with clinical trials for people, which are  
voluntary, participation in this trial is at the  
discretion of the pet owners. Similar to human  
trials, clinical trials involving animals are over-
seen and approved by an independent committee 
that reviews the protocol and decides whether  
all requirements for ethical disclosure are met. 
human and veterinary medicine is not new — 
most recently dubbed the One Health or One 
Medicine movement — it is beginning to gain 
new traction in the human medical community. 
e initiative received a boost in 2012 with the 
publication of e New York Times bestselling 
book “Zoobiquity: e Astonishing Connection 
Between Human and Animal Health.” In it, 
Barbara Natterson-Horowitz, MD, and co-author 
Kathryn Bowers argue for increased collaboration 
between physicians and veterinarians. 
Natterson-Horowitz, a cardiologist at the 
University of California, Los Angeles, noted that 
veterinarian colleagues at the Los Angeles Zoo 
oen consult human doctors and the medical  
literature for insights into how best to treat  
their animal patients. But the reverse — human 
doctors seeking the collective wisdom of animal 
doctors and their agship journals — is a rarity, 
the authors observed.
In the spirit of shared medicine, Curiel  
and Smith have developed a trial using a modi-
ed version of a common canine virus to treat 
canine osteosarcoma. Curiel, who also directs 
Washington University’s Biologic erapeutics 
Center, and his team in St. Louis manufacture the 
viral vectors, freeze them and ship them to Smith.
e therapeutic virus can infect any cell in 
the body, but it is engineered to replicate in bone 
tumor cells. Curiel explains bone tumor cells 
contain a genetic “on” switch required to set the 
altered virus’s replication machinery into action. 
Once the virus infects a bone tumor cell, which 
ips the switch, the virus begins replicating,  
lling up the cell and causing it to explode. 
“We turn the cancer cell into a factory of its 
own destruction,” Smith said. “Rupturing the  
cell also sets loose more viruses that are now  
free to infect other cells.” 
To determine if the virus is working as designed, 
the researchers plan to involve 20 dogs, including 
Gary, in the current trial. Four dogs participated 
in a previous, smaller trial to test the safety of  
the viral treatment, much like human clinical  
trials start with a phase 1 safety trial. According  
to Smith, the experience of one dog in particular 
laid the groundwork for the current trial. 
In late 2006, Nancy Hunter noticed the tell-
tale limp in her rescue greyhound, Pretty. Aer 
receiving the osteosarcoma diagnosis, Hunter 
scoured the Internet and found information about 
While the concept of uniting
Making cancer 
destroy itself
The engineered virus is injected  
into the dog, infects and replicates 
in tumor cells and kills them before 
spreading to repeat the cycle.
Racing greyhounds 
are at greater risk 
for osteosarcoma, 
a fast-moving bone 
cancer that often 
strikes human 
adolescents.
Virus: 
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the investigational viral treatment available at 
Auburn. Pretty had the aected leg amputated, 
received the viral treatment and later underwent 
chemotherapy. 
“She handled the treatment really well,” Hunter 
said. “Aer recovering from the surgery, she went 
back to digging in her sand pile, running around 
the yard and taking long walks. She got around 
great on three legs.” 
At one year, when Hunter took Pretty for 
follow-up X-rays, the vets saw two spots on her 
lungs and suspected the cancer had spread. Upon 
further analysis, the lesions were determined to  
be scar tissue. Most signicantly, these lesions 
were possible evidence of an acquired immune 
response to the tumor. 
In addition to rupturing tumor cells with  
replicating viruses, the treatment may prime the 
dogs’ immune systems to recognize and attack  
the virus-infected cells. 
“If that is the case, we may be creating an envi-
ronment that could allow the immune system to 
start recognizing tumor cells and mount an anti-
tumor immune response,” Smith said. “In other 
words, we’re trying to nd out if the dogs become 
vaccinated against a recurrence of the tumor. 
at’s the question we want to answer in the  
current, larger trial.” 
Pretty ultimately lived two years and four 
months aer diagnosis, more than twice as long 
as the average. Smith said there’s no way to know 
if the experimental treatment was responsible for 
this. But Pretty’s experience and that of the other 
three dogs in the rst trial allowed them to get 
funding for the current one. 
Very early evidence suggests that a subset of 
dogs responds well to the treatment. e rest  
follow the average course. Curiel compares this  
to human treatments in which only a subset of 
patients responds well, pointing to the importance 
of personalized or precision medicine. 
We all want the silver bullet,” Smith said. “But the reality is that cancer is very diverse. is is another reason clini-
cal trials in dogs are excellent models for human 
studies. All the dogs have dierent immune sys-
tems. ey all respond to the world in dierent 
ways, just as people do.”  
According to Curiel, several other cancers 
in dogs are excellent mimics of human disease, 
including melanoma, lymphoma and prostate 
cancer. Partnering with more veterinarians, 
including some at the University of Missouri-
Columbia, Curiel is working to begin canine trials 
to test viral therapies in canine melanoma and 
lymphoma. He is also working with breast cancer 
researchers to look for ways to improve an investi-
gational vaccine against human breast cancer. 
As for Gary, he nished chemotherapy Jan. 30 
and is doing well. Four months post-diagnosis, his 
chest X-rays were clear of signs of tumor spread-
ing. It’s too early to say whether this new treat-
ment has helped, but the Oravetzes are optimistic.
“He’s doing so well, there are times when I for-
get he has cancer,” Dawn Oravetz said. “I just see 
my loving, energetic, three-legged greyhound.
“With osteosarcoma so common in the grey-
hound community, I think a lot of owners are 
willing to participate in trials like this,” she added. 
“But what really geared me toward wanting to do 
the study was the idea that what they learn from 
the greyhounds could potentially help kids with 
osteosarcoma. If what they learn from Gary could 
help children with this cancer, I just think that’s 
an awesome thing.”
David T. Curiel, 
MD, PhD
Beyond osteosarcoma, 
other cancers in dogs mimic 
human disease. These 
also could point toward 
improved therapies.
                    David T. Curiel, MD, PhD
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B Y  D E B  P A R K E R
prep 
Surgery’s seismic  
shift from time-  
to competency-
based training
OR
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F O R 1 0 0  Y E A R S ,
general surgeons have learned their craft in exactly the
same way. As residents, they spent most of their waking
(and non-waking) hours in the hospital, shadowing
more experienced surgeons and jockeying for time
in the O.R. There was no academic curriculum per se;
the patient mix dictated the day’s lesson plan. The
“apprentice” model has remained largely unchanged.
This broad-based surgical field and its proliferation
of increasingly sophisticated tools and techniques —
combined with a U.S. mandate for reduced residency
training hours — is making learning by osmosis all
the more challenging. The ever-expanding body of
knowledge is staggering; the time to learn it has shrunk.
As a result, nationally, general surgical education
is in the midst of transformation. “The next five years
will look nothing like the last 50,” explained Michael
M. Awad, MD, PhD, assistant professor of surgery and
associate dean for medical student education.
At the institutional and national levels, Washington
University educators are devising improved methods
to teach surgical skills. Consistently, School of Medicine
faculty members have been ahead of the curve in
surgical education — crafting a curriculum, employing
skills labs outside the O.R., implementing quantitative
evaluation measures and designing customized
experiences for residents.
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F E W E R  training hours
A number of factors over the past 10 to 15 years 
have altered the training landscape. Declining 
clinical reimbursements require doctors to see 
more patients to make the bottom line, allowing 
less time to teach. And residents are spending 
much less time in the hospital.
In 2003, the Accreditation Council for 
Graduate Medical Education (ACGME) limited 
the resident workweek to 80 hours. is mandate, 
a response to patient advocacy groups, was an 
eort to reduce medical errors. 
“Now that residents are in the hospital less, the 
‘education-by-accident’ model doesn’t work as well,” 
Awad said. “We have to do education by intention.”
e reduction aects all medical residents,  
but surgical training programs, in particular,  
had diculty making the switch. Research indi-
cates a strong link between a surgeon’s operative 
skill, the number of operations performed and 
patient outcomes. 
“Resident graduates today voice a concern about 
their lack of preparedness for independence,” said 
Timothy J. Eberlein, MD, chair of the Department 
of Surgery and surgeon-in-chief at Barnes-Jewish 
Hospital. “Not long aer the introduction of an 
80-hour workweek, there was a national increase in 
the percent of residents failing the certifying exam-
ination of the American Board of Surgery.”
Due to medicolegal concerns, the ACGME 
restrictions tightened again in 2010, calling for 
greater supervision of physicians-in-training. 
Interns now must be directly supervised when per-
forming a critical portion of any procedure. 
In the past, surgical trainees became increas-
ingly autonomous during residency, gaining the 
necessary expertise for independent practice. 
“Before, you could do ve years of residency  
and hang your shingle,” Awad explained. 
Today, however, most aspiring general surgeons 
undertake one to three years of post-residency  
fellowship training to strengthen skills and specialize. 
Residents refine their  
laparoscopic techniques in 
the skills lab. As testament 
to the program’s strength, 
School of Medicine residents 
have won the national Top 
Gun skills competition three  
of the last four years.
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G E N E R A L gets specialized
“General surgery” and “specialization” might  
seem like a contradiction in terms, but the eld’s 
scope is so wide, it’s virtually impossible to  
master all aspects. 
General surgery encompasses the abdomen, 
breast, skin and so tissue, the endocrine system, 
transplants, pediatric surgery, critical care, surgi-
cal oncology (including head and neck surgery), 
emergency surgery, the alimentary tract (including 
bariatric surgery) and vascular surgery. 
“e public also drives the push for specializa-
tion,” Awad said. “If you’re getting your hiatal her-
nia repaired, do you want to go to someone who 
does two or three a year, along with thyroid and 
gallbladder procedures, or do you want to go to 
someone who does 100 of these operations a year?” 
Additional, specialized training time is 
needed, according to a 2013 study in the Annals 
of Surgery. Awad partnered on the multi-insti-
tutional study in which U.S. fellowship directors 
assessed the preparedness of general surgery 
residents aer completing nine years of training 
(medical school and residency). 
e result: 30 percent of fellowship directors 
felt that those entering fellowship could not  
independently perform a gallbladder removal,  
19 percent felt that incoming fellows could  
not suciently operate laparoscopic tools and  
56 percent felt they could not perform laparo-
scopic suture techniques. 
T E C H N O L O G Y  revolution
ese percentages perhaps further underscore the 
breadth of general surgery and the dizzying array of 
laparoscopic, endovascular and robotic techniques. 
e push for better patient outcomes has  
fostered ever-more-minimally invasive procedures. 
ere used to be one way to remove a gallbladder 
— through a ve-inch abdominal incision; now 
there are at least three ways.
At a recent Washington University Mini-
Medical School session geared for the general  
public, audience members gasped in unison as 
they watched a video of a surgeon removing  
an appendix — through the patient’s mouth.  
By passing surgical instruments and a tiny camera 
through a natural opening in the body, the sur-
geon is able to perform incisionless procedures. 
However, it’s not entirely out-with-the-old  
and in-with-the new. Surgeons must be prepared 
to operate the old-fashioned way if complications 
develop, despite less practice with these procedures. 
C R I T I C A L  shor tage
e complexity and added debt and training time 
have made general surgery a less attractive career 
option for medical students, who may prefer to 
match to a non-surgical specialty right out of 
school. “e average medical student is no longer 
the single male who spends 168 hours a week at the 
hospital,” Awad said. “People want a life and fami-
lies. Arguably, that makes for a more well-rounded 
person and doctor.”
In 2003, general surgery nationally had a  
number of unlled residency positions in the 
Main Residency Match; this, combined with 
unlled spots in 2002, served as a wake-up call. 
e country continues to face a general surgeon 
shortage, particularly in rural areas. Almost half 
of U.S. counties have no general surgeons. 
 “It was of concern,” said Mary E. 
Klingensmith, MD, the Department of  
Surgery’s vice chair for education and the Mary 
Culver Distinguished Professor of Surgery.  
“We realized that change was needed to bring  
the best and brightest to our eld to ensure a 
stable workforce for the future.”
Nationally, schools  
are moving away  
from “one-size-fits-
all” programs, instead 
customizing for  
individual aspirations.
Video of the Top Gun 
competition 
wumcnews.org/topgun
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T I M E  for  change
Anticipating many of these pressures, Washington 
University leaders have been retooling the training 
regimen and implemented an 80-hour workweek 
at the medical school before the mandate.
“e ACGME adjusts its rules frequently, 
oen giving advance notice of planned changes,” 
explained Paul Wise, MD, general surgery residency 
program director. “Here, we use ‘future’ regulations 
as our guide. We are a very proactive, progressive, 
almost risk-taking program as opposed to many 
more conservative programs that wait to let others 
sort out what will and won’t work.”
With prototype programs in place, the medical 
school is well poised to lead the national discus-
sion about how best to train future surgeons. 
Klingensmith directs a consortium of eight U.S. 
surgical organizations, known as SCORE, which 
collaborate to develop a unied training curricu-
lum, something that previously did not exist.  
e web-based curriculum is updated annually. 
“We look at the technological advances and ask,  
‘Is that a standard we want to make sure every 
resident is learning?’” Klingensmith explained. 
Nearly two decades ago, Klingensmith, a edg-
ling resident herself, observed as the attending 
physician performed a mastectomy. Suddenly, the 
attending turned to Klingensmith and said, “OK. 
Close it up,” before promptly exiting the room. 
“As I looked down at this young patient, I 
thought, ‘You’ve got to be kidding me. I’m learning 
right now,’” Klingensmith recalled. “I felt enor-
mous pressure to make the incision look as nice 
as I could. I thought if I’m ever in a position to 
change surgical education, I’m going to do some-
thing about this.”
G A I N I N G  proficienc y
Klingensmith, who began directing the general  
surgery residency at Washington University in 
2001, made good on her promise, developing a skills 
training lab outside the O.R. that would expose resi-
dents to graduated levels of experience and provide 
practice opportunities in a low-stress environment. 
A novel concept at the time, only two other 
institutions oered such labs: Southern Illinois 
University-Springeld and the University of Toronto. 
Washington University has made major invest-
ments in the lab, formally the WUSM Institute  
for Surgical Education, accredited as a Level 
1 (top) institute by the American College of 
Surgeons in 2012. Awad, nurse coordinator  
Debbie Tiemann, RN, and surgical technician 
Angelia DeClue, RST, now administer the lab.
“The academy model has 
revolutionized my education.  
I have witnessed that I can 
achieve the same competencies 
much more quickly in this 
streamlined and personalized 
approach.”  ASHLEY M. HOLDER, MD
22  Washington University School of Medicine
Residents win national  
quiz competition
wumcnews.org/quiz
Capstone, a monthlong boot camp, boosts clinical skills  
as fourth-year students transition to residency. Outcomes  
suggest significant increases in proficiency, and the School  
of Medicine program is serving as a national example. 
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Tools range from low-tech plastic body parts to 
highly realistic computer simulators. Students and 
residents can remove a virtual gallbladder before 
ever putting scalpel to esh. Laparoscopic box 
trainers test precision and speed as residents trans-
fer rows of pegs using a video monitor as a guide. 
Trainees also perform progressively challenging 
procedures in animal models and human cadavers. 
“ere isn’t any question that working on fun-
damental skills translates to the operating room,” 
said L. Michael Brunt, MD, professor of surgery 
and chief of the Section of Minimally Invasive 
Surgery and president of the Society of American 
Gastrointestinal and Endoscopic Surgeons (SAGES).
I N D I V I D U A L  experience
Traditionally, surgical residents have received  
little formalized performance feedback. 
Washington University is piloting an “academy 
model” that outlines core competencies and key 
milestones for several general surgery sections. 
“We are moving toward competency-based  
rather than time-based training,” Awad said.
e model stipulates that residents discuss 
learning objectives with faculty as they begin a 
rotation, receive mid-term feedback and undergo 
formal assessment at the end. 
To more accurately gauge trainee performance, 
input is collected from nurses and technicians, as 
well as faculty. Awad then meets personally with 
the resident. If a resident is struggling in a par-
ticular area, he or she is paired up with a senior 
resident for as long as it takes to rene the skill. 
“e academy model has revolutionized my 
education,” said h-year surgical resident Ashley 
M. Holder, MD, who began training at the medical 
school before the model was introduced. “I have 
witnessed that I can achieve the same competen-
cies much more quickly in this streamlined and 
personalized approach.”
Another signicant change nationally is a  
shi away from “one-size-ts-all” programs 
requiring residents to complete identical training 
modules across ve years. 
“As medical care becomes increasingly com-
plex, it’s evident that not every individual needs to 
learn the entire breadth of surgery,” Klingensmith 
said. “For instance, do trainees going into heart 
surgery ever need to do pancreas surgery? Right 
now, that is a requirement. But it may not make  
a lot of sense in the big picture.”
Customizing residency training to individual 
aspirations could maximize the experience — 
reinforcing select skill sets while decreasing the 
dependency on fellowships. 
Klingensmith is leading a nine-institution 
consortium examining exibility in surgical train-
ing. At participating institutions, residents in their 
third, fourth or h years may spend 12 months in 
specialized rotations that will better prepare them 
for their intended areas of practice. e institutions 
are evaluating the eectiveness of such a model 
and collecting data on resident performance. 
Washington University’s general surgery resi-
dency was one of the earliest to develop a “fast 
track” in cardiothoracic (2005) and vascular 
(2006) surgery, allowing senior residents to focus 
on these areas. e vascular surgery section took 
it a step further in 2013; trainees do not enter a 
general surgery residency, but rather spend ve 
years learning vascular surgery almost exclusively, 
with some general surgical skills taught early in 
the program. 
“Training the next generation of surgeons will 
require the types of programs we are developing, 
which are intentional, structured, rigorous and 
customized,” Awad said. “We no longer can  
rely on whatever happens to come through the 
operating room doors.” 
The Department of  
Surgery was among the 
earliest to offer a skills 
training lab outside  
the O.R.
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Washington University 
School of Medicine 
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Match Day 2015
THE FIRST DAY OF SPRING, MARCH 20, also was
the day medical students across the country found
out where they will head for their residency programs,
the next stage in their medical careers.
School of Medicine students gathered at the
Eric P. Newman Education Center for the much-
awaited delivery of envelopes containing news
of where the soon-to-be graduates had matched.
As students approached the microphone one-by-
24  Washington University School of Medicine Spring 2015
C A L I F O R N I A
Los Angeles
University of California,  
Los Angeles
O P H T H A L M O L O G Y
Kirk Hou
R A D I AT I O N  O N C O L O G Y
Naomi Jiang
Riverside
University of California, Riverside, 
School of Medicine
P S Y C H I AT R Y
Kazuo Omi
Sacramento
University of California,  
Davis Medical Center
I N T E R N A L  M E D I C I N E
Vivian Tien
San Diego
University of California, San Diego
D E R M AT O L O G Y
David Cotter
O B S T E T R I C S  G Y N E C O L O G Y
Sarah Lederhandler
O R T H O PA E D I C  S U R G E R Y
Dylan Kluck
P E D I AT R I C S
Leslie Chiang
San Francisco
California Pacific Medical Center
O P H T H A L M O L O G Y
Ann omas
University of California,  
San Francisco
I N T E R N A L  M E D I C I N E
Hailyn Nielsen
O R T H O PA E D I C  S U R G E R Y
Justin Krogue
San Jose
O’Connor Hospital
F A M I LY  M E D I C I N E
Lawrence Zieske
Stanford
Stanford University Programs
E M E R G E N C Y  M E D I C I N E
Alexander Zozula
I N T E R N A L  M E D I C I N E
Madeleine Chollet
O T O L A R Y N G O L O G Y
Varun Chalivendra
P E D I AT R I C S / R E S E A R C H 
T R A C K
Susan Canny
Whittier
Presbyterian Intercommunity 
Hospital
F A M I LY  M E D I C I N E / T R O P I C A L 
M E D I C I N E
Amber Lin
C O L O R A D O
Aurora
University of Colorado
D E R M AT O L O G Y
Jennifer Barklund
C O N N E C T I C U T
Farmington
University of Connecticut  
School of Medicine
O B S T E T R I C S  G Y N E C O L O G Y
Stephanie Higgins
New Haven
Yale-New Haven Hospital
I N T E R N A L  M E D I C I N E / 
P H Y S I C I A N  S C I E N T I S T 
Sandra Williams
D E L A W A R E
Newark
Christiana Care
O B S T E T R I C S  G Y N E C O L O G Y
Kristen Kapalka
Chelsea Kebodeaux
D I S T R I C T  O F  
C O L U M B I A
Washington
Children’s National Medical Center
P E D I AT R I C S
Angelica Wong
F L O R I D A
Miami
Jackson Memorial Hospital
P E D I AT R I C S
Temidayo Adebiyi
G E O R G I A
Atlanta
Emory University  
School of Medicine
I N T E R N A L  M E D I C I N E
Amirhossein Esmaeeli
I L L I N O I S
Chicago
Northwestern McGaw  
Medical Center
I N T E R N A L  M E D I C I N E
Lindsay Forbes
I N T E R N A L  M E D I C I N E / 
D E R M AT O L O G Y
Lida Zheng
Rush University Medical Center
A N E S T H E S I O L O G Y
David Kim
K E N T U C K Y
Lexington
University of Kentucky  
Medical Center
D I A G N O S T I C  R A D I O L O G Y
Leanne Lin
M A R Y L A N D
Baltimore
Johns Hopkins Hospital
I N T E R N A L  M E D I C I N E
Stephanie Wang
Bethesda
Walter Reed National Military 
Medical Center
G E N E R A L  S U R G E R Y
Robert DesPain
M A S S A C H U S E T T S
Boston
Beth Israel Deaconess  
Medical Center
I N T E R N A L  M E D I C I N E
Pankaj Pal
Brigham & Women’s Hospital
I N T E R N A L  M E D I C I N E
Nicholas Yozamp
U R O L O G Y
Valary Raup
Massachusetts General Hospital
A N E S T H E S I O L O G Y
Aaron Rudin
Rachel Steinhorn
D I A G N O S T I C  R A D I O L O G Y
Reece Goiffon
M I C H I G A N
Ann Arbor
University of Michigan Hospitals
E M E R G E N C Y  M E D I C I N E
Alexander Beyer
O T O L A R Y N G O L O G Y
Michael Wilson
P E D I AT R I C S
Michael Triebwasser
Detroit
Children’s Hospital of Michigan
P E D I AT R I C S
Tamara Cooks
Wayne State University/Detroit 
Medical Center
O B S T E T R I C S  G Y N E C O L O G Y
Sarah Cortez
Royal Oak
Beaumont Health System
O R T H O PA E D I C  S U R G E R Y
Kevin Park
Jonathan Wright
M I S S O U R I
St. Louis
Barnes-Jewish Hospital
A N E S T H E S I O L O G Y
Krisztina Escallier
Bradley Fritz
Maxim Wolfson
D E R M AT O L O G Y
Leonid Shmuylovich
Christian Wichterman
E M E R G E N C Y  M E D I C I N E
Kevin Baumgartner
Jarrod Dornfeld 
G E N E R A L  S U R G E R Y  
P R E L I M I N A R Y
Gregory Ebersole
 
one to announce their specialties and where they had
matched, they each placed $1 in a bin. Tradition has it
that the cash goes to the student whose name is called
last. The students are called randomly, so the loot goes to
the person who had to wait the longest for such big news.
Overall, 123 medical students matched in 22
specialties in a total of 23 states. Top specialties included
internal medicine, pediatrics, obstetrics-gynecology,
orthopaedic surgery and anesthesiology.
Doctors learn their futures
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I N T E R N A L  M E D I C I N E
Jordan Atkins  
Stephen Chi
Christopher Chung
Nhila Jagadeesan
Joyce Ji
Ramon Jin
Jimmy Ma
Arvind Rengarajan
Anjali Rohatgi
Stephanie Velloze
Peter Zhao
N E U R O L O G I C A L  S U R G E R Y
Jacob Greenberg
Bhuvic Patel
N E U R O L O G Y
Elyse Everett
Alan Plotzker
O B S T E T R I C S  G Y N E C O L O G Y
Chelsea Bayer
Katherine Smith
Jennifer Travieso
O R T H O PA E D I C  S U R G E R Y
Zachary Meyer
PAT H O L O G Y
Brianna Kolody
Stephen Persaud
P S Y C H I AT R Y
Desiree Baumgartner
Marie Bosch
Allan Jiang
Lauren Marks
Alexander Rose
Max Rosen
St. Louis Children’s Hospital
P E D I AT R I C S
Cori DeSanto
Sarah Ihnen
Natalie Macaruso
Drew Schwartz
Miriam Steinberg
Jessica Tsai
Annie Wang
Julia Warren
Elizabeth Wright-Jin
St. Louis University  
School of Medicine
O R T H O PA E D I C  S U R G E R Y
Kelsey Rebehn
Washington University
O P H T H A L M O L O G Y
Han Li
James Liu
N E W  M E X I C O
Albuquerque
University of New Mexico  
School of Medicine
PAT H O L O G Y
Samuel Anderson
N E W  Y O R K
Bronx
Einstein/Montefiore  
Medical Center
G E N E R A L  S U R G E R Y
Faye Yu
New York Hospital for  
Special Surgery
O R T H O PA E D I C  S U R G E R Y
Lauren Wessel
New York
New York Presbyterian  
Hospital-Columbia
I N T E R N A L  M E D I C I N E
John Blackett
Judith Kim
Rochester
University of Rochester/ 
Strong Memorial
O R T H O PA E D I C  S U R G E R Y
Wajeeh Bakhsh
N O R T H  C A R O L I N A
Chapel Hill
University of North Carolina 
Hospitals
F A M I LY  M E D I C I N E
Alvin Powell
Durham
Duke University Medical Center
O B S T E T R I C S  G Y N E C O L O G Y
Katherine Bishop
O R T H O PA E D I C  S U R G E R Y
Gerald Aggrey
O H I O
Cincinnati
Cincinnati Children’s Hospital
C H I L D  N E U R O L O G Y
Adrienne Brower-Lingsch
University of Cincinnati
O P H T H A L M O L O G Y
Carl Bruce
Cleveland
Cleveland Clinic-Cole Eye Institute
O P H T H A L M O L O G Y
Robert Purgert
Columbus
Ohio State University  
Medical Center
O B S T E T R I C S  G Y N E C O L O G Y
Rahel Ghenbot
O K L A H O M A
Oklahoma City
University of Oklahoma  
College of Medicine
O B S T E T R I C S  G Y N E C O L O G Y
Emily Zantow
P E N N S Y L V A N I A
Philadelphia
Hospital of the University of 
Pennsylvania
A N E S T H E S I O L O G Y
Nicole Shin
I N T E R N A L  M E D I C I N E 
R E S E A R C H
Wumesh K.C.
Jonathan Lake
N E U R O L O G Y
Neena Cherayil
Pittsburgh
University of Pittsburgh  
Medical Center
G E N E R A L  S U R G E R Y
Amelia Lucisano
P E D I AT R I C S
Elise Lu
P L A S T I C  S U R G E R Y  
 I N T E G R AT E D 
Lucas Dvoracek
R H O D E  I S L A N D
Providence
Rhode Island Hospital/Brown 
University
O R T H O PA E D I C  S U R G E R Y
Steven Bokshan
T E X A S
Edinburgh
University of Texas  
Health Science Center
I N T E R N A L  M E D I C I N E
Chi Lun Pui
Houston
Baylor College of Medicine
P H Y S I C A L  M E D I C I N E  & 
R E H A B I L I T AT I O N
Uzoh Ikpeama
University of Texas  
MD Anderson Cancer Center
R A D I AT I O N  O N C O L O G Y
Adnan Elhammali
San Antonio
University of Texas  
Health Science Center
O B S T E T R I C S  G Y N E C O L O G Y
Vaishnavi Purusothaman
W A S H I N G T O N
Seattle
University of Washington  
Affiliated Hospitals
P E D I AT R I C S
Katharine Walz
P L A S T I C  S U R G E R Y 
  I N T E G R AT E D 
Grace Um
W I S C O N S I N
Milwaukee
Aurora St. Luke’s  
Medical Center
D I A G N O S T I C  R A D I O L O G Y
Nyabosamba Binagi
Medical College of Wisconsin  
Affiliated Hospitals
O T O L A R Y N G O L O G Y
Miranda Colletta
P L A S T I C  S U R G E R Y 
  I N T E G R AT E D 
Adam Aronson
Choosing to defer residency:
Carolyn Purgert
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The Elizabeth H. and James S.   
McDonnell III Genome Institute
Leading Together The Campaign for Washington University
New name,  
new era
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G E N OM IC S - BA S E D  R E S E A RC H  is opening  
the door to more precise diagnoses, new disease 
treatments, and the ability to understand people’s  
health needs based on their genetic makeup. In the future, 
individualized DNA analysis  
will lead to a powerful form  
of preventive medicine. 
To help support this 
paradigm shi in medicine, 
civic leaders and longtime 
philanthropists Elizabeth H. 
and James S. McDonnell III 
pledged $25 million to e Genome Institute, which will 
be renamed the Elizabeth H. and James S. McDonnell III 
Genome Institute at Washington University. 
 “is extraordinary gi will enable our top-line 
researchers to set more ambitious goals and step up 
discoveries in the fast-paced world of genomics,” said 
Washington University Chancellor Mark S. Wrighton. 
The Genome Institute’s Richard 
K. Wilson, PhD; Li Ding, PhD; 
Elaine Mardis, PhD; and Robert 
Fulton are among the world’s 
researchers most often cited  
in scientific publications.
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Tracing the roots of disease 
Under the leadership of Director Richard K. Wilson, PhD, 
the Alan A. and Edith L. Wol Distinguished Professor of 
Medicine, and Co-director Elaine Mardis, PhD, the Robert E. 
and Louise F. Dunn Distinguished Professor of Medicine, the 
institute is helping to transform medicine using genomics. 
Founded in 1993, the institute played a key role in the 
Human Genome Project, an international eort to decode  
all 6 billion letters of our genetic blueprint. It ultimately 
helped decode, or sequence, 25 percent of the genome by  
the project’s completion in 2003. e institute also has  
pioneered whole genome sequencing as a way to study cancer 
and other diseases. 
In 2008, using private funds, institute researchers became 
the rst to decode the whole genomes of both healthy and 
tumor cells from a leukemia patient — tracing the disease to 
its genetic roots. is potent mix of technology and ingenu-
ity ushered in a new era, enabling researchers to search the 
entire genome to identify possible cancer-causing mutations.
Even though the institute is one of only three National 
Institutes of Health (NIH)-funded, large-scale sequencing 
centers in the U.S., it has struggled to nd funding for some 
Lukas Wartman, MD, a leukemia 
doctor and researcher, developed 
the disease himself. Colleagues 
sequenced his cancer genome 
and instead treated him with a 
kidney cancer drug. Without the 
sequencing data, doctors say he 
likely would not have survived.
Solving a 6-billion-piece puzzle
Twins streamline the “big data” of genetics to aid clinical care
As sequencers churn out human genome data faster, and researchers better understand 
which “mistakes” in the genetic code 
lead to disease, a question remains:  
how to interpret and catalog the  
6 billion letters of our genetic code  
so that clinicians can use it? 
Obi Griffith, PhD, and Malachi Griffith, 
PhD, are identical twins and members 
of the McDonnell Genome Institute. 
They are streamlining information for 
clinicians and patients to aid in disease 
diagnosis and potential drug therapies. 
The brothers’ interest in pairing drugs 
with genetics is as much personal as it 
is scientific. Their mother died of breast 
cancer just weeks before they graduated 
from high school.
“The more data the better,” said 
Malachi Griffith, assistant professor of 
genetics in bioinformatics and associate 
director at the institute. “But our current 
capacity to deal with it means that it  
can often seem like too much to handle. 
The data is incredibly complex, and a  
lot of it is still unfamiliar to people  
practicing medicine.” 
To date, the brothers and a team of 
software developers have launched two 
open-source websites, the Drug-Gene 
Interaction Database (dgidb.genome.
wustl.edu) and the Database of Curated 
Mutations (docm.genome.wustl.edu). 
“With these tools, oncologists don’t 
have to read 100 papers,” said Obi 
Griffith, assistant professor of medicine 
and assistant director at the institute. 
“They can just get the final end product, 
the recommendation or the actionable 
statement.”
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Obi Griffith, PhD, and Malachi Griffith, PhD
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of its riskier projects. Sequencing the rst whole cancer 
genome was a tough sell, as it was thought to be too expen-
sive and too risky, possibly without much immediate benet. 
e McDonnells, who lost their daughter, Peggy, at age 
2 of neuroblastoma, a common cancer in children, have 
long supported pediatric cancer research. “What appeals 
to us about the institute is its collaboration with St. Louis 
Children’s Hospital, Washington University School of 
Medicine’s Department of Pediatrics and others in the 
application of genomics to pediatric cancers,” said James 
McDonnell III. 
In 2010, to better understand the genetic origins of  
pediatric cancer, the institute launched the St. Jude 
Children’s Research Hospital-Washington University 
Pediatric Cancer Genome Project. e project has led to the 
whole genome sequencing of more than 1,000 childhood 
cancer patients, helping to pinpoint a variety of mutations, 
including a key mutation in pediatric neuroblastoma.
Over the past six years, cancer genomics studies at the 
institute have compared the tumor and normal genomes 
in patients with breast, liver, kidney, brain, lung, skin and 
blood cancers, among others.
 “At some point, we’ll be able to look at many dierent 
patients with the same type of disease and start to under-
stand what’s genetically similar about all these people’s dis-
eases and what’s dierent,” Wilson said. “at information 
eventually will lead to the development of new treatments. 
But even in the short term we can use that information to 
more eectively utilize the drugs we already have on the 
shelf right now.”
Precision therapy
In one clinical study, Lukas Wartman, MD, a patient 
with leukemia, had relapsed twice and run out of options. 
Institute researchers sequenced his genome and discovered 
a mutation that might be treatable instead with a kidney 
cancer drug already on the market. Wartman, who is now 
an assistant professor in the Department of Medicine and an 
assistant director at the institute, took the drug and was able 
to attain remission, allowing him to receive a stem cell trans-
plant. Without the sequencing data, Wartman’s doctors say 
he likely would not have survived. 
“Soon, we’re going to see an era where patients are moni-
tored much more closely, their diagnoses are much more 
precise and individualized and, hopefully, their outcomes are 
much better,” Mardis said. “Side eects will be diminished. 
e days of one-size-ts-all therapeutics will be gone.”
To fulll the promise of putting genomics into clinical  
practice, Wilson said, philanthropy is crucial.
“ere is not a lot of support at this time for clinical 
genomic testing of cancers because it’s still in its infancy,”  
he said. “To take it to the next level and really touch more 
patients, we’ve got to have gis like the McDonnells bring.” 
Family 
legacy
Elizabeth H. and James S. McDonnell III have 
championed research efforts at the School of 
Medicine for many years. 
In 2000, together with Anne, AB ’64, and 
John F. McDonnell and the JSM Charitable Trust, 
they funded the construction of the McDonnell 
Pediatric Research Building. The building was 
dedicated in memory of their daughter,  
Peggy, who died of cancer in 1972 at age 2. 
In 2009, they endowed the Elizabeth  
H. and James S. McDonnell III Distinguished 
Professorship, which was instrumental in 
bringing Dennis Hallahan, MD, a preeminent 
figure in the study of cancers of the brain and 
central nervous system,  
to Washington University. 
“Libby and Jim’s  
philanthropy has 
spawned scientific  
discoveries in nearly every pediatric  
discipline,” said Larry J. Shapiro, MD,  
executive vice chancellor and dean of the 
School of Medicine. “They have championed 
the medical school for many years, and this 
gift demonstrates their exceptional dedica-
tion to ensuring success in many key areas.”
McDonnell’s father, James S. McDonnell Jr.,  
made a gift in the 1960s to establish the 
McDonnell Medical Sciences Building. In 
1968, he endowed the James S. McDonnell 
Professorship in Genetics. And, in 1975,  
he made a gift to create the James S.  
McDonnell Department of Genetics, one  
of the first genetics departments within a  
U.S. medical school. 
Outlook  29
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scholarships
With support from generous alumni, Washington University is helping a new generation of aspiring medical professionals minimize student debt. 
More than 80 percent of its medical students receive 
nancial aid, primarily in the form of scholarships. 
“We’ve always tried to see that anyone who has the  
ability and the desire to be a student at Washington  
University is given the opportunity,” said Larry J. Shapiro, MD, 
executive vice chancellor for medical aairs and dean of the 
School of Medicine. “We’re proud of the fact that our medical 
students have among the lowest debt of any medical students  
in the country,” he said.
e promise of tomorrow
The School of Medicine 
attracts some of the world’s 
best and brightest students. 
Scholarships provide the 
tools they need to 
change the world.
Shirley Sahrmann,
PT, PhD, with
scholarship
recipients
Stacy Jackson
and Matthew
Mastenbrook.
B Y  H I L A R Y  D A V I D S O N
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Psychology of scholarships
Scholarships are a top priority for Gammon 
Earhart, PT, PhD, director of the Program in 
Physical erapy. 
“We want to continue to attract the best and 
the brightest physical therapy students, and to do 
that we need to be sure that they have the support  
they need,” she said. “at includes support from 
our faculty and sta for academic endeavors, but 
also nancial support so they know that they can 
graduate with a manageable debt load,” she said. 
Scholarships also have psychological benets, 
Earhart said. “Students who receive scholarships 
feel welcomed. ey feel like we have identied 
them as the best of the best and that we really 
want them to be here.” 
Matthew Mastenbrook, DPT ’17, would agree. 
“I really want to work hard to show that I deserve 
the scholarship, and that I can make the person 
who gave it proud,” he said.
Shirley Sahrmann, PT, PhD, professor emerita 
of physical therapy, has created two scholarships, 
including the one awarded to Mastenbrook, and 
plans to create more as she leads fundraising 
eorts among alumni.
Sahrmann wants to help talented students  
“be at peace” with the choices they have made, and 
live their lives without the worry of student debt.
Sahrmann said that the program’s strong 
research component, an outgrowth of collabora-
tions with the medical school, oers students the 
opportunity to “do incredible things.” “Students 
are exposed in every which way to people who  
are on the cutting edge.”
Such a dynamic environment can’t help but 
produce top practitioners and leaders, she said.  
“I get to travel around the country, and I’m always 
so pleased when I hear from clinicians saying, 
‘Oh, we hired one of your amazing graduates,’” 
Sahrmann said. 
 “To think I can play some little role in helping 
people get on with their lives not only as profes-
sionals, but also in their personal lives, is really 
important to me.”  
Reasons for giving
Retired Col. William P. Wiesmann, MD ’72,  
president and CEO of bioSTAR Inc., created  
scholarships because he wants others to “experi-
ence the wonderful things” he experienced at 
Washington University. 
 “When I came as a freshman I could get into  
a laboratory right away and start doing research 
with some very wonderful people,” he said.  
“I had the chance to do some really fundamental 
basic science. I was able to write papers in medical 
school, which was a fantastic opportunity for me.  
It set me on my career path at that point.” 
Wiesmann spent the majority of his career as 
a research scientist for government organizations 
such as NASA, and later became an entrepreneur. 
“I’ve been looking back and thinking, ‘What 
were the things that made a dierence in my life, 
and allowed me to get to where I am?’” Wiesmann 
said. “Some of those things have to do with being 
free to do what you want to do — being free to be 
passionate about what you love to do.” 
A full-tuition scholarship enabled Vernetta 
Harris, MD ’04, to graduate from the School  
of Medicine with relatively little debt. Harris 
e promise of tomorrow
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AVERAGE AMOUNTS OF STUDENT DEBT
began practicing medicine in Atlanta, and eventu-
ally became a medical director of an emergency 
department in Tennessee. Being on sound nan-
cial footing allowed her to make the move, she 
said. “I felt like I was empowered to make changes, 
some call it risk, without thinking of the nancial 
consequences.” 
Harris also took some time o from clinical 
practice to participate in relief eorts in Ghana 
and Jamaica. “I would not have been able to do 
that so early in my career if I had had a large 
amount of nancial stress.” 
Harris funds scholarships to help others in  
the way she was helped.
“I know how big a boost and blessing it was  
to me, and I wanted to provide that to other  
students. Hardworking, talented students  
should be rewarded.” 
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Rodger and Paula Riney know all too well the  devastating eects of Alzheimer’s disease.“My mother struggled with it for quite a long 
time,” said Rodger Riney, the founder and CEO of Scottrade, 
a nationwide discount retail brokerage rm. “It was just  
the most awful thing to watch.”
Paula Riney has a similar story. “My dad passed away  
just over three years ago aer battling Alzheimer’s for 12  
to 13 years,” she said. “It was one of the saddest things I’ve 
ever experienced.”
e couple became involved with the Alzheimer’s 
Association, St. Louis chapter, and ultimately decided to 
make a signicant investment toward research. 
 “We felt that we wanted to do something a little more 
substantive,” Rodger Riney said. “Certainly something needs 
to happen because the cost of Alzheimer’s on society is just 
devastating and it doesn’t get the attention of other diseases.” 
“We just felt like we needed to do more,” added Paula Riney. 
e couple discussed various initiatives of the univer-
sity’s Charles F. and Joanne Knight Alzheimer’s Disease 
Research Center (Knight ADRC) with its director, John C. 
Morris, MD, the Harvey A. and Dorismae Hacker Friedman 
Distinguished Professor of Neurology. e Rineys decided  
to support School of Medicine researcher Beau Ances, 
MD, PhD, who they previously had met at an Alzheimer’s 
Association event. 
“We thought he was a terric guy,” said Rodger Riney. 
Ances, an associate professor of neurology aliated with 
the Knight ADRC, is seeking biomarkers and developing 
imaging techniques to help researchers visualize amyloid 
and tau deposits in the brain. ese protein deposits are 
hallmarks of Alzheimer’s. Amyloids form clumps outside  
of brain cells that disrupt neural networks, Ances said,  
while tau deposits form “tangles,” which twist and destroy 
communication pathways. 
Studies by the Knight ADRC have shown that tau and 
amyloid can start to show up in the brain 15 to 20 years 
before symptoms manifest. 
“A lot of changes go on in this early preclinical phase,” 
Ances said. “Even though the individual is very normal,  
he or she already has pathology.” 
While amyloid imaging has been used extensively in 
Alzheimer’s research studies, Washington University is  
one of the few sites worldwide that can image tau. ese  
tau deposits can be viewed with labeled radioisotopes  
and a PET scanner, Ances explained.
Better imaging techniques will help researchers pinpoint 
the disease mechanisms, he added, and identify therapies 
that could stop the disease or delay onset. 
 “My biggest hope is that we could nd something to  
stop it in its tracks,” said Paula Riney.
Against Alzheimer’s disease
Rineys honor their parents through commitment to research
Furthering efforts to 
mitigate the impact  
of Alzheimer’s disease
David M. Holtzman, MD, the 
Andrew B. and Gretchen P. Jones 
Professor and head of the 
Department of Neurology,  
Paula and Rodger Riney, and  
Beau Ances, MD, PhD, associate 
professor of neurology.
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classnotes
1940 S 
Elliot Luby, MD 49, received a 
Distinguished Service Award from Wayne 
State University School of Medicine 
in Detroit for his 60 years of training, 
research and clinical care at the institution.
1960 S 
George Bohigian, HS 69, LA 61,  
gave the Charles A. Snyder Lecture at the 
annual meeting of the Cogan Ophthalmic 
History Society in Monterey, Calif. He is a 
professor of clinical ophthalmology and 
visual sciences at WUSM.
1970 S 
Susan Cigelman, PT 76, recently retired 
as vice president for academic affairs at 
AIB College of Business in Des Moines, 
Iowa. Prior to this position, she served  
as director of the physical therapy  
program at Des Moines University from 
1987 to 2003.
David Dooley, MD 79, continues his 
responsibility with resident, fellow and 
medical student education at the South 
Texas VA and University Hospital. He also 
teaches internal medicine and infectious 
diseases to trainees.
1980 S 
Gina Musolino, PT 87, was re-elected 
to a second term as Florida chief del-
egate to the American Physical Therapy 
Association, House of Delegates.
John Constantino, MD 88, was awarded 
the 2014 Irving Phillips Award for 
Prevention from the American Academy 
of Child & Adolescent Psychiatry for sig-
nificant contributions to the prevention of 
mental illness in children and adolescents. 
He is the Blanche F. Ittleson Professor of 
Psychiatry and Pediatrics at WUSM.
Andrew Sonin, MD 88, LA 84, was 
inducted as a fellow in the American 
College of Radiology. He is a diagnostic 
radiologist and a clinical assistant  
professor of radiology at the University  
of Colorado.
1990 S 
Dale Horne, MD 90, LA 82, recently 
accepted a position with the Mayfield 
Clinic & Spine Institute in Cincinnati. He is 
a board member and past president of the 
Ohio State Neurosurgical Society, secretary 
of the Northwest Quadrant of the Council 
of State Neurosurgical Societies, and a fel-
low of the American College of Surgeons.
Jeff Boris, MD 91, is a clinical profes-
sor of pediatrics at the University of 
Pennsylvania and a pediatric cardiologist 
in the outpatient clinic and director of the 
Postural Orthostatic Tachycardia Syndrome 
Program at Children’s Hospital of 
Philadelphia. He also chairs the American 
College of Cardiology Foundation/
American Heart Association Task Force for 
Data Standards for the Electronic Health 
Record, specific to pediatric and congeni-
tal cardiology.
Grant Hoekzema, MD 92, was named 
chair of the Council of Academic Family 
Medicine in 2013-14 and recently 
completed a term as president of the 
Association of Family Medicine Residency 
Directors. He is program director for  
Mercy Family Medicine-St. Louis.
2000 S 
Stefan Schulz, PT 01, is lead ergonomist 
with Briotix, a workforce performance 
company.
Laura VanZandt, OT 08, was married 
Aug. 30, 2014.
I M
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Edna Dependahl, NU 45
Dependahl died Tuesday, Dec. 9, 2014. 
She was 91. Dependahl worked at 
Normandy Osteopathic Hospital for many 
years. An avid gardener, she was a docent 
at the Missouri Botanical Garden for 45 
years. She was married to the late Eugene 
Dependahl for 50 years. Dependahl is  
survived by children Deborah, Frances 
and Carol; and three grandchildren.
Birkle Eck, MD 42, LA 38
Eck died Wednesday, Sept. 17, 2014. He 
was 97. During undergraduate study 
at Washington University, he served as 
class president and did so again while at 
WUSM. After finishing a medical degree, 
Eck joined the U.S. Army, serving in Africa, 
Italy and Japan and achieving the rank of 
major before leaving active duty service 
in 1945. He served a residency at the VA 
Medical Center at Jefferson Barracks. He 
later opened a private practice in Clayton, 
Mo., and served on the Deaconess 
Hospital staff. The last 10 years of his 
career were spent as medical director  
at Mari de Villa Retirement Center. He is 
survived by his wife of nearly 53 years, 
Mary Lea Eck.
Albert Eisenstein, MD 44
Eisenstein died Thursday, Dec.18, 2014. 
He earned a bachelor’s degree from the 
University of Missouri before attending 
WUSM. During World War II, he was a U.S. 
Army captain. Before moving to New York 
in 1968, Eisenstein served as professor 
of medicine at Washington University 
and chief of internal medicine at Jewish 
Hospital. In New York, he served as pro-
fessor of medicine at Downstate Medical 
School and chief of internal medicine 
at Gouveneur Hospital. After retiring 
to Florida, he became volunteer physi-
cian and medical director of the Senior 
Friendship Center for about 30 years. 
Eisenstein is survived by his wife of 73 
years, Barbara; five children, Robert, Sylvia, 
Lesley, James and Richard; and 11 grand-
children and 17 great-grandchildren.
Harry Allen Fozzard, MD
Fozzard, a pioneer in the study of cardiac 
muscle activity and the Otho S.A. Sprague 
Distinguished Professor Emeritus in the 
Department of Medicine at the University 
of Chicago, died Tuesday, Dec. 9, 2014. 
He was 83. He attended Washington & 
Lee University and WUSM and interned at 
Yale University. He served in the U.S. Navy 
Corps at Camp Lejeune in 1957-59 and 
remained in the reserves, retiring in 1969 
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as lieutenant commander. He completed 
his internal medicine residency and car-
diology training at Washington University 
and obtained his research training in 
cardiac electrophysiology at the University 
of Bern, Switzerland. After several years 
in St. Louis, he joined the faculty of the 
University of Chicago in 1966. His special 
clinical interest was cardiac arrhythmias, 
and he was a pioneer in the establishment 
of coronary care units, use of beta blockers 
in management of myocardial infarction, 
computerized rhythm monitoring, and 
invasive cardiac electrophysiology. His 
basic research was on the biophysics of 
cardiac rhythm, leading to 160 experimen-
tal articles, 60 reviews and editorials and 
several books. He was vice president of 
the American Heart Association, editor-
in-chief of the AHA Journal Circulation 
Research, AHA Distinguished Scientist, and 
member of multiple National Institutes of 
Health review panels. An honorary doctor-
ate was awarded to him in Montevideo, 
Uruguay, where he was a Fulbright Scholar, 
and he was a member of the U.S.-U.S.S.R. 
scientific exchange program in medicine 
1983–1998. He was elected to the honorific 
American Society for Clinical Research and 
the Association of American Physicians, and 
fellowship in the American Association for 
the Advancement of Science. Perhaps his 
greatest legacy in science was his mentor-
ship of some 60 graduate students and 
postdoctoral trainees, most of whom now 
teach in universities around the world. He 
is survived by his wife of 61 years, Lyn; two 
sons, Richard and Peter; his four grandchil-
dren; his brother, George; and his nephew.
Guy Harper, MD 52
Harper died Sunday, Aug. 24, 2014. He 
was 91. Born in Steele, Mo., Harper served 
in the European Theater from 1943 to 
1945 during World War II. He graduated 
from the University of Missouri before 
attending WUSM. Harper completed an 
internship and residency at Methodist 
Hospital of Indianapolis, Ind., before 
beginning a private practice as a family 
physician in Charleston, lll. He is survived 
by his wife of 62 years, Dorothy; children, 
Chrys, Robin, Reg, Jill and Roy; 10 grand-
children; and brother, Bobby Joe.
Betty Owen Knoblock, NU 51
Knoblock died Saturday, Oct. 25, 2014. 
She was 85. Born in St. Louis, she 
attended Iowa State University before 
achieving a nursing degree at Washington 
University. She was a head nurse at Barnes 
Hospital and met future husband, Dr. 
James Owen Jr. After the couple moved 
to Oklahoma, Knoblock suspended her 
nursing career to be a full-time mother 
and volunteer. She was president of the 
Service League and a longtime member 
of First Presbyterian Church of Bartlesville. 
Several years after the death of her hus-
band, she married Richard Knoblock, who 
also preceded her in death. Knoblock is 
survived by her three sons, Jim, John and 
David; three daughters from her second 
marriage, Jane, Susan, and Trish; and  
nine grandchildren, as well as many 
nieces and nephews.
Edgar Nathaniel Lockett Jr., MD 45
Lockett died Monday, Oct. 20, 2014. He 
was 93. Lockett served as medical officer 
in the U.S. Navy during World War II. He 
later was a surgeon at the VA Hospital in 
Marion, Ill., and practiced internal medi-
cine at the VA Hospital in Lake City, Fla. 
He was proud to serve as chairman of 
the deacons and Sunday school director 
at his church. His wife of 56 years, Helen, 
preceded him in death. He is survived 
by his sister, Kathryn; sons, Edgar, John, 
David and Jerry; nine grandchildren and 
12 great-grandchildren.
I M
F A C U L T Y
Herman Eisen, MD
Eisen, head of the Department of 
Molecular Microbiology at WUSM from 
1961-1973, died Sunday, Nov. 2, 2014.  
He was 96. Eisen earned a medical degree 
from New York University in 1943 and 
was a member of its faculty from 1950-
55. He came to Washington University 
in 1955 as a professor of medicine in the 
Division of Dermatology. Eisen authored 
the immunology section of an influen-
tial 1970s textbook on microbiology for 
medical students. He retired in 1989 from 
Massachusetts Institute of Technology, 
but, as a professor emeritus of biology, 
maintained an active lab at the university. 
As head of the Department of Molecular 
Microbiology at Washington University, 
Eisen oversaw the recruitment of several 
faculty members and supervised the 
department’s move to the McDonnell 
Medical Sciences Building in 1970.  
Among his survivors is his wife, Natalie.
John “Jack” Gilster, DE 44
Gilster, professor emeritus of pediatric 
dentistry at Washington University School 
of Dentistry, died Wednesday, Aug. 6, 
2014. He was 92. Born in Chester, Ill., 
Gilster graduated from the University 
of Illinois in 1940 and the Washington 
University School of Dentistry in 1944. 
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He served two years in the U.S. Army 
and three years in a general practice in 
Illinois before establishing a private prac-
tice in pediatric dentistry. He joined the 
Washington University faculty in 1950 and 
taught pediatric dentistry until his retire-
ment in 1987. During that time, he also 
served on the American Board of Pediatric 
Dentistry, as president of the North 
District of the St. Louis Dental Society 
and as president of the Missouri Society 
of Dentistry for Children. He was named 
a Distinguished Alumnus of Washington 
University in 1987. After retirement, he 
moved to Albuquerque, N.M. Gilster is 
survived by his children, John, Norman 
and Elisabeth, and six grandchildren.
David B. Gray, PhD
Gray, a professor of occupational therapy 
and neurology who worked tirelessly 
to improve the lives of people with dis-
abilities, died Thursday, Feb.12, 2015. 
He was 71. Gray became motivated to 
change what it means to be disabled after 
he was paralyzed in 1976 in a fall from a 
roof that broke his neck. He went on to 
work for several agencies at the National 
Institutes of Health (NIH), was appointed 
director of the National Institute on 
Disability and Rehabilitation Research 
by President Ronald Reagan and was an 
important advocate for the Americans 
with Disabilities Act of 1990. He was pres-
ent when President George H.W. Bush 
signed the bill into law. Gray joined the 
School of Medicine faculty in 1995 to con-
duct research and teach courses on social 
issues and disability. He was the visionary 
behind the internationally recognized 
Enabling Mobility Center, now called the 
Health and Wellness Center, located at 
Paraquad, an independent living center 
in St. Louis. Gray was passionate about 
developing personalized interventions to 
help individuals fully participate in their 
everyday life activities. His work on the 
role that the environment can play in 
determining whether a person with dis-
abilities can fully participate in an activity 
is internationally recognized. Realizing 
unemployment was a major problem 
for people with mobility limitations, he 
developed a program to study people 
with disabilities who had been success-
fully employed for two years. He created 
videos to tell their stories and made the 
videos available to potential employers. 
Additionally, Gray developed programs 
for parents with mobility limitations. 
Gray was born in Grand Rapids, Mich. He 
graduated from Lawrence University in 
1962 with a bachelor’s degree in psychol-
ogy. Gray later earned a master’s degree 
in experimental psychology from Western 
Michigan University, in 1970, and a doc-
torate in psychology and genetics from 
the University of Minnesota, in 1974. 
Survivors include his wife of 47 years, 
Margaret “Margy”; his son, David; two 
daughters, Elizabeth and Polly; a sister, 
Priscilla; two brothers, Fred and William; 
and two grandchildren. 
James P. Keating, MD
Keating, a meticulous physician who 
helped mold hundreds of medical resi-
dents, organized the first pediatric inten-
sive care unit west of the Mississippi and 
was sought for his ability to solve mystery 
illnesses, died Thursday, Dec. 25, 2014, in 
Cary, N.C. He was 76. Keating, a professor 
emeritus of pediatrics at WUSM and the 
inaugural W. McKim Marriott, MD, Chair in 
Pediatrics at St. Louis Children’s Hospital, 
died from a pulmonary embolism. In a 
career spanning 44 years at the university 
and St. Louis Children’s Hospital, Keating’s 
impact was far-ranging. In 1971, he estab-
lished the pediatric gastroenterology and 
nutrition division in the Department of 
Pediatrics and served as its director until 
1992. Recognized as one of that field’s 
founders, Keating helped develop many 
now-standard approaches to patient care. 
As an early proponent of pediatric inten-
sive care, Keating shaped the first pediat-
ric intensive care unit in St. Louis and was 
its director from 1980-1992. Keating also 
pioneered the concept of pediatric diag-
nostic medicine, founded such a division 
in 1992 and served as its director until his 
retirement. Digging for elusive answers in 
medicine was a passion. Keating and his 
colleagues discovered a significant cause 
of water intoxication — a potentially 
fatal condition — in infants. They found 
that 3- to 6-month-olds living in poverty 
suffered the illness disproportionately 
because their caretakers were more likely 
to run out of formula and instead feed 
infants water. Keating’s position as director 
of the pediatric residency program, which 
he held from 1969-2002, was among the 
roles he loved most. A demanding teacher, 
he was both feared and revered by the 
legions of residents he trained. Keating 
was born in Braddock, Pa. His father was 
killed in a mill accident when Keating 
was 11, leaving his mother to raise four 
children. Keating earned an academic 
scholarship to Harvard, where he went 
on to receive an undergraduate degree 
and attend Harvard Medical School. He 
worked at Massachusetts General Hospital 
and then served as a U.S. Navy lieutenant 
at a civilian hospital in Vietnam during 
the Vietnam War. Among other honors, 
he received the Navy Commendation 
for Valor. After retiring in 2012, Keating 
moved to North Carolina. His survivors 
include his wife, Susan; daughter, Amy; 
son, Thomas; sister, Mary; and brothers, 
Larry and Jerry.
Herbert Rosenbaum, HS 51
Rosenbaum, professor emeritus of neu-
rology at WUSM, died Wednesday, Dec. 
10, 2014. He was 90. Distinguished as 
a clinical neurologist, diagnostician, 
outstanding teacher and dedicated sup-
porter of Washington University and 
Barnes-Jewish Hospital, Rosenbaum was 
widely respected for his contributions 
to students and trainees. He taught the 
Practice of Medicine course for 61 years 
and mentored many residents during 
his tenure. Rosenbaum attended the 
University of Oregon for bachelor’s and 
medical degrees before completing resi-
dency and training at Barnes Hospital. 
He served for two years as a neurologist 
in the U.S. Air Force during the Korean 
War before joining WUSM faculty in 
1954. Rosenbaum was a member of the 
American Academy of Neurologists and 
the Clinical Society of Neurology. He was 
awarded the Distinguished Service Award 
by the Washington University Medical 
Alumni Association in April 2014. Survivors 
include his wife, Velma; children, Robert, 
Barbara and Nancy; stepdaughter, Diana; 
and several grandchildren and step-
grandchildren. 
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John C. Morris, MD
Harvey A. and Dorismae Hacker Friedman Distinguished  
Professor of Neurology; Director, Charles F. and Joanne Knight 
Alzheimer’s Disease Research Center
Childhood dream: 
To play for the Cleveland Browns in the National Football League
Guess that didn’t work out. What did?
Wrestling — Athletic Hall of Fame inductee, Ohio Wesleyan University
What are you most grateful for?
After my family, it is all the talented faculty, staff and dedicated  
volunteers of the Knight ADRC!
Favorite honor:
One award with great personal significance is the Dr. Neville Grant 
Award for Clinical Excellence from Barnes-Jewish Hospital and 
Washington University Physicians. It means my peers  
consider me a good doctor!
Proudest moment:
Most recently it is the birth of my first grandchild,  
Jack, as he represents the next generation of  
what is most important — my family.
I support the School of Medicine because:
Washington University has been so  
supportive of me, and I am most  
pleased to give back.
Consult with your legal or tax adviser before making a charitable gift.
Like Dr. Morris, consider supporting  
Washington University School of  
Medicine through an estate gift,  
life income plan or other planned gift. 
To learn more, visit plannedgiving.wustl.edu  
or call 800.835.3503.
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Dissecting 
Vesalius
Marking 500 years since the birth of Andreas Vesalius,
the father of modern anatomy, Washington University and
Saint Louis University co-hosted an interdisciplinary symposium.
The three-day event included a roster of internationally
renowned speakers and a dramatic re-creation in the Eric P.
Newman Center — complete with an actor in a cadaver suit.
Above, performers portray the intellectual struggle between
25-year-old Vesalius and aged professor Matthaeus Curtius.
Authorities such as Curtius revered the writings of ancient
Greek physician Galen. Vesalius instead championed “the body
over the book.”  His inquiring mind would come to define a
new era of anatomical exploration.
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beckerexhibits.wustl.edu/
vesalius
Video — Faculty discuss 
Vesalius’ lasting impact: 
wumcnews.org/vesalius
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Voices heard  First- and second-year medical students 
recently met with legislators at the Missouri State Capitol in Jefferson City.  
The cohort discussed issues of importance to the next generation of doctors. 
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